An Open Label, Three-period, Single Sequence Study to Evaluate the Pharmacokinetic Drug-drug Interaction Between LCZ696 and Sildenafil in Subjects With Mild to Moderate Hypertension

Trial Profile

An Open Label, Three-period, Single Sequence Study to Evaluate the Pharmacokinetic Drug-drug Interaction Between LCZ696 and Sildenafil in Subjects With Mild to Moderate Hypertension

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Oct 2015

At a glance

  • Drugs Sacubitril/valsartan (Primary) ; Sildenafil (Primary)
  • Indications Hypertension
  • Focus Pharmacokinetics
  • Sponsors Novartis
  • Most Recent Events

    • 01 Jan 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 11 Aug 2012 Actual initiation date (8 Aug 2012) added as reported by European Clinical Trials Database record.
    • 11 Aug 2012 New source identified and integrated (European Clinical Trials Database record; EudraCT2012-001632-64).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top